Cargando…
Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology
[Figure: see text]
Autores principales: | Chatur, Safia, Fu, Edouard, Vaduganathan, Muthiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308051/ https://www.ncbi.nlm.nih.gov/pubmed/37397081 http://dx.doi.org/10.1016/j.jaccao.2023.05.003 |
Ejemplares similares
-
Rationale and proposed framework for shared decision making in cardio-oncology
por: Hull, Sarah C., et al.
Publicado: (2021) -
Cardio-Oncology Considerations in Oncologic Treatment Decisions
por: Fadol, Anecita P.
Publicado: (2022) -
Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care
por: Rangaswami, Janani, et al.
Publicado: (2020) -
On the importance of interpretable machine learning predictions to inform clinical decision making in oncology
por: Lu, Sheng-Chieh, et al.
Publicado: (2023) -
Cardio-Oncology Guidelines and Strength of the Evidence
por: Zheng, Haoyi, et al.
Publicado: (2023)